The Causes Of Neuroendocrine Colon Carcinoma

Feb 24
13:42

2009

Paul Abbey

Paul Abbey

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

The colon is a major part of the large intestine, whereas a carcinoma is a malignant cancer that crops up from epithelial cells.

mediaimage

One of the more agressive and worst types of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that more often than not it is detected late into the advanced stages at which time it is more difficult to do anything about it.

As the effects of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient drops drastically Existing tumors are mostly detected with distant metastases. Surveys show the reports have revealed that most of the cases of neuroendocrine cancer ends in death.

Though chances of neuroendocrine carcinoma in colon are rare at best if one is affected the patient’s condition becomes much worse than those who are suffering from adenocarcinoma.

Research shows that the end results of this form of cancer stay the same with age,The Causes Of Neuroendocrine Colon Carcinoma Articles sex or tumor location. But neuroendocrine colon carcinoma  depends on which stage the tumor is in Normal trends have revealed that people in stage 1 and 2 of cancer do not suffer from neuroendocrine colon cancer. Though in many cases if said tumor is in stage 3 or 4, it is a laborious and tough job to treat the neuroendocrine colon carcinoma.

It is unfortunate that medical science has very few methods to treat this kind of cancer. A more common technique that doctors might use is immunohistochemical staining methods. This method helps doctors in dealing with the severity of the neuroendocrine colon cancer and really helps determine the most helpful medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. Involved in that, is the staining of the tumor with a monoclonal antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and the amount of damage on the health of the patient.

Neuroendocrine colon carcinoma is difficult to treat and a case study in which several patients stuffered from this particular disease underwent examination and, it was observed that the overall survival rate related to this disease was only about seven months. In the later stages these rates drop to less than five months Most cases were initially detected as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a poor prognosis and surgery may not be a guaranteed treatment so, even surgery does not even cure the patient. so it is critical to notice the presence of this disease as soon as possible and administer the proper treatment.